✦ LIBER ✦

Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study

✍ Scribed by Fritz H. Schröder; Chris H. Bangma; Johannes M. Wolff; Antonio Alcaraz; Francesco Montorsi; Pierre Mongiat-Artus; Per-Anders Abrahamsson; Tom A. McNicholas; Ramiro S. Castro; Indrani M. Nandy

Book ID: 109055661
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 186 KB
Volume: 103
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2009.08373.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of nilutamide in men wi

A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy

✍ Nancy B. Davis; Christopher W. Ryan; Walter M. Stadler; Nicholas J. Vogelzang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

A pilot study of use of the cyclooxygena

A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy

✍ R.S. Pruthi; J.E. Derksen; D. Moore 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Utility of tissue microarrays for profil

Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors

✍ Nariculam, Joseph; Freeman, Alex; Bott, Simon; Munson, Phillipa; Cable, Noriko; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 449 KB